SQUAWK/NEWS
Menu
Live News EQUITY L impact

Monte Rosa Therapeutics Files SEC Form

Monte Rosa Therapeutics submits filing to SEC. The company is a biotech firm.

ROSN

Filed: 2026-05-27 AccNo: 0001969223-26-000596 Size: 5 KB